SCHEMBL18405263

SCHEMBL18405263

C/C=C/C(=N)c1cccc(C)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ ACHE P22303 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HPGD P15428 2/20 0.40
▸ KCNK3 O14649 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ KCNK9 Q9NPC2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ GPR52 Q9Y2T5 1/20 0.39
▸ FAAH O00519 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20313308 1.00 PARP1 (0.46) PARP1HDAC8HDAC6ACHESMN1; SMN2
SCHEMBL23815322 0.83 PARP1 (0.48) PARP1HDAC8HDAC6ACHESMN1; SMN2
SCHEMBL25732483 0.79 PRSS1 (0.48) ALDH1A1HPGD
SCHEMBL24710508 0.78 TDP1 (0.50) PARP1HDAC8HDAC6ACHESMN1; SMN2
SCHEMBL19288105 0.78 PARP1 (0.47) PARP1HDAC8HDAC6ACHESMN1; SMN2
SCHEMBL17117831 0.78 PARP1 (0.40) PARP1HDAC8HDAC6ACHESMN1; SMN2
SCHEMBL17273799 0.77 F2 (0.42) ACHEALDH1A1MAPTHPGDMEN1
SCHEMBL11813974 0.77 GPR52 (0.56) PARP1HDAC8HDAC6SMN1; SMN2ALDH1A1
SCHEMBL1348921 0.77 GPR52 (0.56) PARP1HDAC8HDAC6SMN1; SMN2ALDH1A1
SCHEMBL11813977 0.77 GPR52 (0.56) PARP1HDAC8HDAC6SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509602-B1 PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS SENHWA BIOSCIENCES INC (TW) 2017-01-25 — — EP disclosed
Send feedback